image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 4.21
2.43 %
$ 674 M
Market Cap
-421.0
P/E
BALANCE SHEET
471 M ASSETS
-57.20%
817 M LIABILITIES
82.39%
-346 M EQUITY
-53.08%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Ironwood Pharmaceuticals, Inc.
image
Current Assets 233 M
Cash & Short-Term Investments 92.2 M
Receivables 129 M
Other Current Assets 12 M
Non-Current Assets 238 M
Long-Term Investments 0
PP&E 18.2 M
Other Non-Current Assets 220 M
Current Liabilities 276 M
Accounts Payable 7.83 M
Short-Term Debt 203 M
Other Current Liabilities 65.6 M
Non-Current Liabilities 541 M
Long-Term Debt 513 M
Other Non-Current Liabilities 28.4 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007
ASSETS
Cash & Cash Equivalents 92.2 656.2 620.1 362.6 177.0 173.2 125.7 54.0 261.3 74.3 75.5 136.7 87.3 44.3 123.1 67.7 62.4
Short Term Investments 0 0 0 0 0 0 95.7 251.2 178.1 174.0 122.1 31.5 76.7 203.7 0 22.0 29.5
Receivables 129.1 115.5 114.0 122.4 117.2 81.0 82.2 64.9 54.5 25.8 3.2 1.5 0.7 2.9 5.2 7.1 25.5
Inventory 0 1.2 1.2 1 0.6 0 0.7 1.1 0 5.0 22.1 6.7 0 (239.9) 0 2.5 0
Other Current Assets 12.0 9.0 11.1 10.9 11.9 12.3 7.3 9.0 6.3 10.6 6.2 8.0 2.9 8.2 5.7 11.2 1.7
Total Current Assets 233.3 780.6 745.2 495.8 306.9 266.4 311.6 380.2 500.2 289.7 229.1 184.4 167.6 259.1 131.4 108.1 119.2
PP&E 18.2 20.3 22.9 25.5 30.2 17.3 17.3 20.5 21.1 29.8 37.4 37.5 33.6 34.4 22.6 24.6 4.1
Intangible Assets 3.7 0 0 0 0 0 159.9 166.1 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0.8 0.8 0.8 0.8 0.8 0 0 0 0 0 0 0 0 0
Long Term Investments 0 15.1 24.5 37.0 64.9 47.4 115.2 140.8 95.2 0 0 0 0 0 0 0 0
Other Long Term Assets 3.6 15.9 25.5 37.1 64.9 47.6 116.1 142.2 2.6 14.0 12.5 7.9 7.8 7.9 8.5 8.0 12.6
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 471.1 1 100.5 1 126.9 559.2 402.7 332.1 605.7 709.8 619.1 333.5 279.0 229.9 209.0 301.4 162.5 140.7 135.9
LIABILITIES
Accounts Payable 7.8 0.5 0.9 0.7 5.5 14.9 16.0 17.7 8.6 9.8 10.2 21.7 6.4 4.3 4.8 3.7 5.6
Short Term Debt 202.7 6.1 120.0 6.3 2.3 47.6 8.2 12.5 30.2 13.6 2.3 0.5 0.5 0.4 1.6 1.1 1.0
Other Current Liabilities 64.3 18.3 40.6 25.3 32.3 57.0 41.9 61.0 30.5 30.0 23.5 29.3 21.9 19.7 17.7 30.7 7.5
Total Current Liabilities 276.1 25.5 161.7 32.7 40.9 119.5 66.0 91.1 76.5 60.5 41.0 54.9 65.1 64.4 56.4 39.2 29.9
Long Term Debt 512.9 412.9 355.8 450.6 452.2 366.3 396.1 366.7 354.2 163.3 177.8 0.3 0.4 0.4 1.9 1.1 2.0
Deferred Tax Income 0 0 0 0 0 0 0 0 81.7 (2.6) 8.8 11.6 (0.4) (14.6) (0.1) (0.2) 0
Other Liabilities 28.4 9.8 3.5 13.9 2.9 42.6 133.7 185.3 91.5 12.1 10.5 12.6 12.4 14.6 308.8 273.4 223.8
Total Liabilities 817.4 448.1 521.0 496.6 496.0 528.4 595.8 643.1 524.0 245.0 240.7 85.9 99.1 141.8 460.8 371.1 314.3
EQUITY
Common Stock 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 99 K 8 K 7 K 7 K
Retained Earnings (1 698.6) (696.4) (937.6) (1 466.1) (1 572.2) (1 591.1) (1 308.8) (1 191.8) (1 110.1) (967.4) (777.8) (505.0) (432.4) (367.5) (314.6) (243.4) (189.5)
Other Accumulative Comprehensive Income/Loss (3.0) 0 0 0 0 0 79 K 7 K 86 K 19 K 2 K 5 K 6 K 1 K (298.4) 23 K 3 K
Total Equity (346.3) 652.4 605.9 62.6 (93.3) (196.4) 9.8 66.7 95.1 88.6 38.2 144.1 109.9 159.6 (298.3) (230.4) (178.4)
Total Liabilities and Equity 471.1 1 100.5 1 126.9 559.2 402.7 332.1 605.7 709.8 619.1 333.5 279.0 229.9 209.0 301.4 162.5 140.7 135.9
SHARES OUTSTANDING
Common Shares Outstanding 155.4 154.4 162.2 159.4 156.0 152.6 148.4 144.9 142.2 136.8 115.9 106.4 99.9 89.7 7.1 6.9 7.1